Efficacy and Safety of 12-week Monotherapy With Once Daily 5 mg Tadalafil for Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: Evidence-based Analysis

Background: Tadalafil has been approved for the treatment of benign prostatic hyperplasia (BPH) for nearly 10 years. However, there are insufficient evidence-based studies of the efficacy and safety of tadalafil in treating lower urinary tract symptoms of BPH (LUTS/BPH). Objective: To evaluate the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Jianwei, Cao, Dehong, Bai, Yunjin, Wang, Jiahao, Yin, Shan, Wei, Wuran, Xiao, Yunfei, Wang, Jia, Wei, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545998/
https://www.ncbi.nlm.nih.gov/pubmed/34712682
http://dx.doi.org/10.3389/fmed.2021.744012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545998/
https://www.ncbi.nlm.nih.gov/pubmed/34712682
http://dx.doi.org/10.3389/fmed.2021.744012

Ejemplares similares